Torrent Pharmaceuticals has raised Rs 200 crore through Commercial Papers (CPs) on September 20,2024. Maturity of the said CPs will be on December 19, 2024. The company has issued CPs at interest rate of 7.32% per annum. 

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.